Tissue iodoprotein formation during the peripheral metabolism of the thyroid hormones.
The formation of tissue iodoproteins during the peripheral metabolism of the thyroid hormones was examined by determining the concentration of nonethanol-extractable (125)I (NE(125)I) in various tissues after the intravenous injection of 3,5,3'-triiodo-L-thyronine (T3-(125)I) and L-thyroxine-(125)I (T4-(125)I) in groups of rats with iodide-blocked thyroid glands. 3 days after T3-(125)I and 7 days after T4-(125)I injection the concentration of NE(125)I in the liver and kidney was 5-10 times greater than in plasma. Smaller but nonetheless significant concentrations of NE(125)I were demonstrated in skeletal and cardiac muscle. Hepatic subcellular fractionation studies revealed that the major portion of the liver NE(125)I was in the microsomal fraction. Lower concentrations of NE(125)I were present in the nuclear, mitochondrial, and soluble fractions. When similar studies were performed in groups of rats pretreated with phenobarbital, an increase in the metabolic clearance of T3-(125)I (30%) and T4-(125)I (100%) was observed along with a highly significant increase in the NE(125)I concentration of the liver and plasma. The increase in hepatic NE(125)I in these studies was primarily due to the microsomal component. Incubation of hepatic microsomes with T3-(125)I and T4-(125)I showed that NEI formation as well as deiodination appeared to obey simple Michaelis-Menten kinetics. Moreover, the maximal rate of both deiodination and NEI formation was increased when microsomes harvested from phenobarbital-treated rats were employed. These studies indicate that thyroid hormone metabolism results in the formation of structural and soluble tissue iodoproteins in addition to circulating iodoproteins. The rate of formation of these moieties in the liver and plasma appears to be related to the rate of hormone metabolism.
D000818:Animals; D002467:Cell Nucleus / Q000378:metabolism; D007455:Iodine / Q000097:blood / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008861:Microsomes / Q000378:metabolism; D008862:Microsomes, Liver / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D013974:Thyroxine / Q000378:metabolism*; D014284:Triiodothyronine / Q000378:metabolism*
D014284:Triiodothyronine; D007455:Iodine; D013974:Thyroxine; D010634:Phenobarbital
Endocrinology. 1968 Feb;82(2):406-9
4952728
J Clin Invest. 1968 Jun;47(6):1399-406
5653217
C R Seances Soc Biol Fil. 1964;158:12-7
14147462
J Natl Cancer Inst. 1950 Feb;10(4):969-75
15415734
J Biol Chem. 1955 Apr;213(2):837-41
14367344
Endocrinology. 1961 Jul;69:30-8
13703211
Nature. 1959 Jan 10;183(4654):116
13622712
Nature. 1960 Sep 17;187:1025-6
13775429
Bull Soc Chim Biol (Paris). 1961;43:727-42
14465829
Gen Comp Endocrinol. 1963 Jun;3:226-38
13964397
J Biol Chem. 1966 Apr 10;241(7):1636-43
4957769
Biochemistry. 1967 May;6(5):1249-61
6036826
J Clin Invest. 1969 Apr;48(4):685-95
5774106
J Biol Chem. 1962 Nov;237:3499-505
14002130
Biochem J. 1960 Nov;77:214-26
13775427
Endocrinology. 1969 Feb;84(2):270-6
5764302
Ann N Y Acad Sci. 1957 Aug 30;70(1):56-68
13488254
J Biol Chem. 1962 Jun;237:1892-7
14008634
Endocrinology. 1957 Oct;61(4):426-47
13473777
J Clin Endocrinol Metab. 1962 Oct;22:978-88
13983345
Nature. 1969 Mar 29;221(5187):1262-3
5773848
J Biol Chem. 1957 Oct;228(2):801-11
13475361
Biochem J. 1963 Oct;89:114-23
14097352
Biochem J. 1961 Mar;78:652-7
13736240
Bull Soc Chim Biol (Paris). 1961;43:743-70
14465823
J Physiol. 1967 Jul;191(1):167-76
6050612
Endocrinology. 1952 Nov;51(5):427-43
13010198
Endocrinology. 1962 Feb;70:210-20
13896496